Nikolai Bespalov
Nikolai Bespalov is a director of development at RNC Pharma, an analytical company specializing in the pharmaceutical market. He is known for providing insights into the supply and demand of essential medications, particularly in relation to the current challenges facing the availability of carbamazepine and its derivatives in Russia.
Not in the pool (under ¢1).
Recent news mentions
Nikolai Bespalov is the director of development at RNC Pharma.
Треть врачей высказались против назначения БАДов — РБК
Russia· 2026-02-24
Nikolai Bespalov, the director of development at RNC Pharma, stated that the supply of anti-Rh immunoglobulin does not meet the country's full needs.
Аналитики зафиксировали рост цен на иммуноглобулин для беременных — РБКRussia· 2026-01-13
Nikolai Bespalov is the director of development at an analytical company who estimated the daily revenue of pharmacy networks.
К чему приведет хакерская атака на аптечные сети и «Семейного доктора» — РБКRussia· 2025-07-30
Nikolai Bespalov noted that the revenue figures provided by 'Kontur.Fokus' include the entire volume of the company's business.
В России сократилось количество новых фармкомпаний — РБКRussia· 2025-07-17Nikolai Bespalov is the director of development at RNC Pharma who noted the growth in pharmacy sales.
Аналитики увидели возвращение потребления лекарств к доковидному уровню — РБКRussia· 2025-02-26
Nikolai Bespalov, the director of the analytical company RNC Pharma, commented on the market situation regarding the drug.
Производитель возобновил поставки дефицитного препарата от эпилепсии — РБКRussia· 2025-02-11
Nikolai Bespalov, the director of the analytical company RNC Pharma, commented on the market situation regarding the drug.
Производитель возобновил поставки дефицитного препарата от эпилепсии — РБКRussia· 2025-02-11Nikolai Bespalov, the director of the analytical company RNC Pharma, commented on the market situation regarding the drug.
Производитель возобновил поставки дефицитного препарата от эпилепсии — РБКRussia· 2025-02-11Nikolai Bespalov, the director of the analytical company RNC Pharma, commented on the market situation regarding the drug.
Производитель возобновил поставки дефицитного препарата от эпилепсии — РБКRussia· 2025-02-11Nikolai Bespalov is the development director of the analytical company RNC Pharma.
Производитель возобновил поставки дефицитного препарата от эпилепсии — РБКRussia· 2025-02-11Nikolai Bespalov, the director of the analytical company RNC Pharma, commented on the market situation regarding the drug.
Производитель возобновил поставки дефицитного препарата от эпилепсии — РБКRussia· 2025-02-11